000			02274 a2200637 4500
005			20250516073501.0
264		0	_c20121126
008			201211s 0 0 eng d
022			_a1097-0142
024	7		_a10.1002/cncr.27418 _2doi
040			_aNLM _beng _cNLM
100	1		_aShimoni, Avichai
245	0	0	_aA randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma. _h[electronic resource]
260			_bCancer _cOct 2012
300			_a4706-14 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnalysis of Variance
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCarmustine _xadministration & dosage
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Administration Schedule
650	0	4	_aEarly Termination of Clinical Trials
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aRecurrence
650	0	4	_aRisk Factors
650	0	4	_aSample Size
650	0	4	_aStem Cell Transplantation
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Outcome
700	1		_aAvivi, Irit
700	1		_aRowe, Jacob M
700	1		_aYeshurun, Moshe
700	1		_aLevi, Itai
700	1		_aOr, Reuven
700	1		_aPatachenko, Paulina
700	1		_aAvigdor, Abraham
700	1		_aZwas, Tzila
700	1		_aNagler, Arnon
773	0		_tCancer _gvol. 118 _gno. 19 _gp. 4706-14
856	4	0	_uhttps://doi.org/10.1002/cncr.27418 _zAvailable from publisher's website
999			_c21468099 _d21468099